Your browser doesn't support javascript.
loading
Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/ß-Catenin Activation.
Bhagat, Tushar D; Chen, Si; Bartenstein, Matthias; Barlowe, A Trevor; Von Ahrens, Dagny; Choudhary, Gaurav S; Tivnan, Patrick; Amin, Elianna; Marcondes, A Mario; Sanders, Mathijs A; Hoogenboezem, Remco M; Kambhampati, Suman; Ramachandra, Nandini; Mantzaris, Iaonnis; Sukrithan, Vineeth; Laurence, Remi; Lopez, Robert; Bhagat, Prafullla; Giricz, Orsi; Sohal, Davendra; Wickrema, Amittha; Yeung, Cecilia; Gritsman, Kira; Aplan, Peter; Hochedlinger, Konrad; Yu, Yiting; Pradhan, Kith; Zhang, Jinghang; Greally, John M; Mukherjee, Siddhartha; Pellagatti, Andrea; Boultwood, Jacqueline; Will, Britta; Steidl, Ulrich; Raaijmakers, Marc H G P; Deeg, H Joachim; Kharas, Michael G; Verma, Amit.
Afiliação
  • Bhagat TD; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Chen S; Erasmus Medical Center Cancer Institute, Department of Hematology and Erasmus Stem Cell Institute, Rotterdam, the Netherlands.
  • Bartenstein M; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Barlowe AT; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Von Ahrens D; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Choudhary GS; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Tivnan P; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Amin E; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Marcondes AM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Sanders MA; Division of Oncology, University of Washington, Seattle, Washington.
  • Hoogenboezem RM; Erasmus Medical Center Cancer Institute, Department of Hematology and Erasmus Stem Cell Institute, Rotterdam, the Netherlands.
  • Kambhampati S; Erasmus Medical Center Cancer Institute, Department of Hematology and Erasmus Stem Cell Institute, Rotterdam, the Netherlands.
  • Ramachandra N; University of Kansas, Kansas City, Kansas.
  • Mantzaris I; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Sukrithan V; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Laurence R; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Lopez R; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Bhagat P; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Giricz O; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Sohal D; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Wickrema A; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Yeung C; University of Chicago, Chicago, Illinois.
  • Gritsman K; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Aplan P; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Hochedlinger K; National Institutes of Health, Bethesda, Maryland.
  • Yu Y; Harvard University, Boston, Massachusetts.
  • Pradhan K; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Zhang J; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Greally JM; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Mukherjee S; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Pellagatti A; Columbia University, New York, New York.
  • Boultwood J; Bloodwise Molecular Haematology Unit, NDCLS, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom.
  • Will B; Bloodwise Molecular Haematology Unit, NDCLS, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom.
  • Steidl U; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Raaijmakers MHGP; Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
  • Deeg HJ; Erasmus Medical Center Cancer Institute, Department of Hematology and Erasmus Stem Cell Institute, Rotterdam, the Netherlands. amit.verma@einstein.yu.edu kharasm@mskcc.org jdeeg@fhcrc.org m.h.g.raaijmakers@erasmusmc.nl.
  • Kharas MG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. amit.verma@einstein.yu.edu kharasm@mskcc.org jdeeg@fhcrc.org m.h.g.raaijmakers@erasmusmc.nl.
  • Verma A; Division of Oncology, University of Washington, Seattle, Washington.
Cancer Res ; 77(18): 4846-4857, 2017 09 15.
Article em En | MEDLINE | ID: mdl-28684528
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Epigênese Genética / Proteínas Wnt / Beta Catenina / Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Epigênese Genética / Proteínas Wnt / Beta Catenina / Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article